Serious adverse events (SAEs) observed in the 3 cohorts
| . | No. of patients, n=33 . | No. of SAEs . |
|---|---|---|
| Totals of subjects and events | 9 | 10 |
| Herpes zoster | 1 | 1 |
| Pneumonia | 1 | 1 |
| Sinusitis | 1 | 1 |
| Neutropenia | 2 | 2 |
| Hemolytic anemia | 1 | 1 |
| Angina pectoris | 1 | 1 |
| Cytolytic hepatitis | 1 | 1 |
| Carotid artery stenosis | 1 | 1 |
| Interstitial lung disease | 1 | 1 |
| . | No. of patients, n=33 . | No. of SAEs . |
|---|---|---|
| Totals of subjects and events | 9 | 10 |
| Herpes zoster | 1 | 1 |
| Pneumonia | 1 | 1 |
| Sinusitis | 1 | 1 |
| Neutropenia | 2 | 2 |
| Hemolytic anemia | 1 | 1 |
| Angina pectoris | 1 | 1 |
| Cytolytic hepatitis | 1 | 1 |
| Carotid artery stenosis | 1 | 1 |
| Interstitial lung disease | 1 | 1 |